Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_assertion type Assertion NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_head.
- NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_assertion description "[Alterations in P16ink4 or in the gene encoding one of its ligands, cyclin-dependent kinase 4 (CDK4), have been reported in human glioma cell lines and primary tumors but not in primitive neuroectodermal tumors (PNETs), the most common malignant brain tumor of childhood.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_provenance.
- NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_assertion evidence source_evidence_literature NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_provenance.
- NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_assertion SIO_000772 8847566 NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_provenance.
- NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_assertion wasDerivedFrom befree-20150227 NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_provenance.
- NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_assertion wasGeneratedBy ECO_0000203 NP301594.RACcRacEHMGzEhIv3ESwLn7iwp3mSnUV9BTP3C146tFws130_provenance.